Nastech Pharmaceutical Company Inc. to Present at the Invest Northwest CEO & Investor Forum

  
    
  
  
    
      Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) announced today that 
      it will present at the Invest Northwest CEO & Investor Forum on Tuesday, 
      March 18, 2008, at 4:30 p.m. Pacific Time at the Bell Harbor 
      International Conference Center in Seattle, Washington.
    
    
      To access the live audio webcast for this conference, please log on to 
      Nastech’s Web site at http://www.nastech.com 
      approximately 15 minutes prior to the presentation in order to register 
      and download any necessary software. A replay of the audio presentation 
      will be available following the event.
    
    
      About Nastech
    
    
      Nastech is a clinical stage biopharmaceutical company focusing on the 
      development and commercialization of innovative therapeutic products 
      based on its proprietary molecular biology-based drug delivery 
      technologies and, through its wholly-owned subsidiary, MDRNA, Inc., 
      based on its proprietary ribonucleic acid interference (RNAi) 
      technology. Nastech and its collaboration partners are developing 
      products for multiple therapeutic areas including osteoporosis, obesity, 
      diabetes, autism, respiratory diseases and inflammatory conditions. 
      Additional information about Nastech is available at http://www.nastech.com.